Evolution of hepatic fibrosis and steatosis during long-term use of metformin in patients with type 2 diabetes

被引：0
|
作者：
Lee, Hye Won [1 ]
Kim, Seung Up [1 ]
Lee, Jae Seung [1 ]
Kim, Beom Kyung [1 ]
Park, Jun Yong [1 ]
Kim, Do Young [1 ]
Ahn, Sang Hoon [1 ]
Han, Kwang-Hyub [1 ]
机构：
[1] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea
来源：
JOURNAL OF HEPATOLOGY | 2020年 / 73卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
THU032
引用
收藏
页码：S156 / S157
页数：2
相关论文
共 50 条
  • [1] Hepatic steatosis predicts fibrosis in long-term methotrexate use
    Tomaszewski, Marcel
    Dahiya, Monica
    Mohajerani, Amir
    Ko, Hin Hin
    Punja, Hanaa
    Ramji, Alnoor
    JOURNAL OF HEPATOLOGY, 2020, 73 : S232 - S232
  • [2] Evolution of liver fibrosis and steatosis markers in patients with type 2 diabetes after metformin treatment for 2 years
    Lee, Hye Won
    Lee, Jae Seung
    Kim, Beom Kyung
    Park, Jun Yong
    Kim, Do Young
    Ahn, Sang Hoon
    Kim, Seung Up
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2021, 35 (01)
  • [3] Triple therapy with pioglitazone/exenatide/metformin prevents hepatic fibrosis and steatosis in type 2 diabetes
    Lavrynenko, O.
    Abdul-Ghani, M.
    Alatrach, M.
    Puckett, C.
    Adams, J.
    Cersosimo, E.
    Alkhouri, N.
    DeFronzo, R. A.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S66 - S67
  • [4] High prevalence of hepatic steatosis and hepatic fibrosis in patients with type 2 diabetes mellitus
    Gupta, Aanchal
    Anoop, Shajith
    Ansari, Irshad Ahmad
    Prakash, Satya
    Misra, Anoop
    CLINICAL NUTRITION ESPEN, 2021, 46 : 519 - 526
  • [5] Effect of insulin-metformin combination on hepatic steatosis in patients with type 2 diabetes
    Lingvay, Ildiko
    Raskin, Philip
    Szczepaniak, Lidia S.
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2007, 21 (03) : 137 - 142
  • [6] The Long-Term Cardiovascular Effects of Metformin on Patients with Newly Diagnosed Type 2 Diabetes
    Yue, Tong
    Wang, Xulin
    Zhao, Minzhe
    Weng, Jianping
    Luo, Sihui
    Zheng, Xueying
    DIABETES, 2023, 72
  • [7] LONG-TERM EVOLUTION LIVER TUMORIGENESIS, STEATOSIS AND FIBROSIS SCORES AFTER INTRAPORTAL ISLET TRANSPLANTATION IN TYPE 1 DIABETES
    Benomar, K.
    Pigny, P.
    Mathurin, P.
    Boury, S.
    Caiazzo, R.
    Pattou, F.
    Kerr-Conte, J.
    Vantyghem, M. C.
    TRANSPLANT INTERNATIONAL, 2016, 29 : 6 - 6
  • [8] Hepatic steatosis as measured by the computed attenuation parameter predicts fibrosis in long-term methotrexate use
    Tomaszewski, Marcel
    Dahiya, Monica
    Mohajerani, Seyed Amir
    Punja, Hanaa
    Ko, Hin Hin
    Sun, Muxin
    Ramji, Alnoor
    CANADIAN LIVER JOURNAL, 2021, 4 (04): : 370 - 380
  • [9] Diabetes: Long-term metformin exposure linked with peripheral neuropathy in patients with type 2 diabetes mellitus
    Osório J.
    Nature Reviews Endocrinology, 2010, 6 (3) : 121 - 121
  • [10] Effect of Canagliflozin on Markers of Hepatic Steatosis and Fibrosis in Patients With Type 2 Diabetes and CKD
    Koshino, Akihiko
    Oshima, Megumi
    Arnott, Clare G.
    Fletcher, Robert A.
    Perkovic, Vlado
    Heerspink, Hiddo J. L.
    Neuen, Brendon L.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 673 - 674
12345